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Xiaofei Zhao, Xiangguo Liu and Ling Su*Abstract
Background: Parthenolide (PTL) is a sesquiterpene lactone which can induce apoptosis in cancer cells and
eradicate cancer stem cells such as leukemia stem cells, prostate tumor-initiating cells and so on. However, the
mechanism remains largely unclear.
Methods: Lung cancer cells were treated with parthenolide and the cell lysates were prepared to detect the given
proteins by Western Blot analysis, and the cell survival was assayed by SRB and MTT assay. Cell cycle was evaluated
by DNA flow cytometry analysis. TNFRSF10B, PMAIP1, ATF4 and DDIT3 genes were knocked down by siRNA
technique. Apoptosis was evaluated by using Annexin V-FITC/PI staining and flow cytometry analysis.
Results: Parthenolide (PTL) induces apoptosis and cell cycle arrest in human lung cancer cells. Moreover, PTL
treatment in NSCLC cells increases expression of TNFRSF10B/DR5 and PMAIP1/NOXA. Silencing of TNFRSF10B or
PMAIP1 or overexpression of CFLAR /c-FLIP (long form) could protect cells from PTL-induced apoptosis. Furthermore,
PTL could increase the levels of endoplasmic reticulum stress hallmarks such as ERN1, HSPA5, p-EIF2A, ATF4 and DDIT3.
Knockdown of ATF4 and DDIT3 abrogated PTL-induced apoptosis, which suggested that PTL induced apoptosis in
NSCLC cells through activation of endoplasmic reticulum stress pathway. More importantly, we found that ATF4, DDIT3,
TNFRSF10B and PMAIP1 were up-regulated more intensively, while CFLAR and MCL1 were down-regulated more
dramatically by PTL in A549/shCDH1 cells than that in control cells, suggesting that PTL preferred to kill cancer
stem cell-like cells by activating more intensive ER stress response in cancer stem cell-like cells.
Conclusion: We showed that parthenolide not only triggered extrinsic apoptosis by up-regulating TNFRSF10B and
down-regulating CFLAR, but also induced intrinsic apoptosis through increasing the expression of PMAIP1 and
decreasing the level of MCL1 in NSCLC cells. In addition, parthenolide triggered stronger ER stress response in
cancer stem cell-like cells which leads to its preference in apoptotic induction. In summary, PTL induces apoptosis
in NSCLC cells by activating endoplasmic reticulum stress response.
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Parthenolide is a sesquiterpene lactone derived from the
plant feverfew. It is used to treat inflammation due to its
ability of inhibiting NF-κB activity [1]. Parthenolide has also
been reported to play other roles such as promoting cellular
differentiation, causing cells to exit cell cycle and inducing
apoptosis [2,3]. Its pro-apoptotic effect on cancer cells is
known to trigger the intrinsic apoptotic pathway which in-
cludes elevated levels of intracellular reactive oxygen spe-
cies (ROS) and alteration of BCL2 family proteins [4-6].* Correspondence: suling@sdu.edu.cn
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stated.What’s more, recent studies have revealed that PTL could
selectively eradicate acute myelogenous leukemia stem
and progenitor cells [7]. It is also demonstrated that PTL
could preferentially inhibit breast cancer stem-like cells [8],
but the molecular mechanism was still unclear.
There are two major pathways contributing to apoptotic
signaling: the extrinsic death receptor pathway and the
intrinsic mitochondrial pathway [9]. Death receptor 5
(TNFRSF10B) is a protein that belongs to tumor necrosis
factor receptor (TNFR) superfamily [10]. It contains a
cytoplasmic death domain (DD) which can recruit Fas-
Associated Death Domain (FADD) and caspases to form
the Death-Inducing Signal Complex (DISC) when thetd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited. The Creative Commons Public Domain Dedication
ain/zero/1.0/) applies to the data made available in this article, unless otherwise
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are activated and lead to the cleavage of downstream effec-
tors. The activation of CASP8 can be regulated by FLICE-
like inhibitor protein (CFLAR) which prevents recruitment
of CASP8 to DISC [12,13]. Development of pro-apoptotic
agonists has been focused on TNFRSF10B because of its
target selectivity for malignant over normal cells [14,15].
The imbalance among the BCL2 family members which
have been defined as either anti-apoptotic or pro-apoptotic
is essential for the modulation of intrinsic pathway [16,17].
The BH3-only protein PMAIP1 is a p53 transcriptional
target in response to DNA damage [18]. It has been re-
ported to be involved in chemotherapeutic agent-induced
apoptosis [19]. PMAIP1 can interact with MCL1 which is a
pro-survival BCL2 protein, then displacing BCL2L11 from
the MCL1/BCL2L11 complex and freeing BCL2L11 to
trigger the intrinsic pathway [20]. This association can also
promote proteasomal degradation of MCL1 to enhance the
mitochondrial apoptosis [21].
Chemotherapy has been reported to induce ER stress
response in cancer cells [22]. ER stress is usually caused
by accumulation of misfolded or unfolded proteins in the
ER lumen. When those proteins are not resolved, ER
stress is prolonged to induce apoptosis [23,24].There are
several mechanisms linking ER stress to apoptosis such as
cleavage and activation of pro-CASP12 and activation of
ASK1 [25]. Many studies have focused on the ER stress
effector DDIT3, which is a downstream target of ATF4
[26]. DDIT3 is a bZIP-containing transcription factor that
can target several apoptotic genes including TNFRSF10B
and PMAIP1 [27]. The molecular mechanisms of ER
stress-induced apoptosis still require further study.
Cancer stem cells have many similar aspects with stem
cells. Those cells have the ability of self-renewal and dif-
ferentiation, express typical markers of stem cells [28].
They are also considered to be the origin of cancer cells
and are rather resistant to active drugs. Many reports
have indicated that cancer stem cells are correlated with
poor clinical prognosis [29,30]. So, targeting cancer stem
cell may be a promising strategy for cancer therapy. PTL
could preferentially inhibit cancer stem cells, but the
molecular mechanism was still unclear.
In our study, we explored the mechanism signaling path-
ways involved in PTL-induced apoptosis in non-small cell
lung cancer (NSCLC) cells and the role of ER stress in
this process. We also found a potential mechanism why
PTL would selectively eradicate cancer stem-like cells,




Parthenolide and PMAIP1 antibody were purchased from
Calbiochem (Darmstadt, Germany). Briefly, parthenolidewas dissolved in dimethyl sulfoxide (DMSO) at a concentra-
tion of 10 mmol/L, and the aliquots were stored at -20°C.
Stock solutions were diluted to the desired concentra-
tions with growth medium before use. The antibodies of
TNFRSF10B and ACTB were purchased from Sigma-
Aldrich (St. Louis, MO, USA). CDH1 and CFLAR anti-
bodies were obtained from BD Biosciences (San Jose, CA,
USA) and Alexis (San Diego, CA) respectively. Anti-
CASP8, CASP9, HSPA5, MCL1, p-EIF2A, and PARP1 anti-
bodies were purchased from Cell Signaling Technology
(Danvers, MA, USA). CASP3 anti-body was obtained from
Imgenex (San Diego, CA, USA). Antibodies of ATF4,
DDIT3 were obtained from Santa Cruz (Santa Cruz, CA).
Cell lines and cell culture
Human lung cancer cell lines were obtained from the
American Type Culture Collection (Manassas, VA). Cells
were gown in monolayer culture with RPMI 1640 medium
containing 5% new born calf serum at 37°C in a humidified
atmosphere consisting of 5% CO2 and 95% air. The A549/
Ctrl, A549/CFLAR, H157/Ctrl, H157/CFLAR, A549/shCtrl
and A549/shCDH1 stable cell lines are established earlier
by infection with lentiviral production [31,32].
Cell survival assay
Cells were seeded in 96-well plates and treated on the
second day with the given concentration of PTL for an-
other 48 hours and then subjected to SRB or MTT assay.
For SRB assay, live cell number was estimated as described
earlier [33]. After treatment, the medium was discarded
firstly. In order to fix the adherent cells, 100 μ1 of cold
trichloroacetic acid (10% (w/v)) were adding to each well
and incubating at 4°C for at least 1 hour. The plates were
then washed five times with deionized water and dried in
the air. Each well were then added with 50 μ1 of SRB solu-
tion (0.4% w/v in 1% acetic acid) and incubated for 5 min
at room temperature. The plates were washed five times
with 1% acetic acid to remove unbound SRB and then air
dried. The residual bound SRB was solubilized with 100 μ1
of 10 mM Tris base buffer (pH 10.5), and then read using a
microtiter plate reader at 495 nm. The MTTassay was exe-
cuted following the manufacturer’s protocol of Cell Prolifer-
ation Kit I (Roche Applied Science, Brandford, CT, USA).
20 μl MTT (5 mg/ml) were added to each sample and incu-
bate at 37° for 4 h, then 100 μl solubilization solution were
added. Cell viability was determined at 595 nm.
Cell cycle analysis
Cell cycle was evaluated by DNA flow cytometry analysis.
Cells were treated with different concentrations of PTL
(0, 5, 10, 20 μM) for 24hours. After treatment, the cells
were harvested and washed twice with ice PBS, then
fixed in 70% ethanol at -20°C overnight. Before analysis,
cells were washed again with ice PBS, incubated with PI
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Then samples were analyzed by FACScan flow cytometer
(Becton Dickinson, San Jose, CA) [34].
Western blot analysis
Whole cell protein lysates were prepared and analyzed by
Western blot according to the protocol described previously
[35]. Cells were harvested and rinsed with pro-cold PBS.
Then cell extracts were lysed and centrifuged at 4°C for 15
minutes. Whole cell protein lysates (40 μg) were elec-
trophoresed through 12% denaturing polyacrylamide slab
gels and then transferred to a Hybond enhanced chemilu-
minescence (ECL) membrane by electroblotting. The pro-
teins were probed with the appropriate primary antibodies
and subsequently with secondary antibodies. The antibody
binding was detected by the ECL system (Millipore, Billerica,
MA, USA), according to the manufacturer’s protocol.
siRNA transfection
siRNAs targeting sequences of TNFRSF10B, ATF4 and















































































Figure 1 Parthenolide inhibits cell growth (A, B) and induces apoptosis in
The indicated cell lines were seeded in 96-well plates and treated with the give
assay (A) and MTT assay (B). Points: mean of four replicate determinations; bars
for 24 hrs (C) or treated with 20 μmol/L PTL for various lengths of time and harGenePharma (Shanghai, China) [36]. The target sequence
of PMAIP1 is 5′-GGAAGUCGAGUGUGCUACU-3′. The
transfection of siRNA was following the manufacturer’s
protocol of X-tremeGENE Transfection Reagent (Roche
Molecular Biochemicals, Mannheim, Germany). Cells were
seeded in 6-well plates and transfected with control or
target siRNA on the second day. Cells were treated with
indicated concentration of PTL for another 24 hours and
harvested for Western blot analysis or Annexin V assay.
Apoptosis assay
Apoptosis was evaluated using Annexin V-FITC/PI
apoptosis detection kit purchased from BIO-BOX Biotech
(Nanjing, China) following the manufacturer’s instructions.
Briefly, 2×106cells were harvested and washed twice
with pre-cold PBS and then resuspended in 500 μl binding
buffer. 5 μl of annexin V-FITC and 5 μl of Propidium
Iodide (PI) were added to each sample and then incu-
bated at room temperature in dark for 10 minutes.
Analysis was performed by FACScan flow cytometer
(Becton Dickinson, San Jose, CA).A549
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a concentration-dependent (C) and a time-dependent manner (D).
n concentration of PTL for 48 hrs. Cell survival was estimated using SRB
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Parthenolide effectively inhibits the growth of human
lung cancer cells through induction of apoptosis and cell
cycle arrest
It has been reported that parthenolide has antitumor effects
on various cancer cells. Hence, we examined the inhibition
effect of PTL on human NSCLC cells by treating the cells
with various concentrations for 48 h and then conducting
SRB and MTT assay. As is shown, PTL had a dose-
dependent growth inhibition effect on NSCLC cells Calu-1,
H1792, A549, H1299, H157, and H460 (Figure 1A, B). To
characterize the mechanism by which PTL induces growth
inhibition in human NSCLC cells, we first determined the
effect of PTL on induction of apoptosis by western blot
analysis. The data showed that PTL could induce cleavage
of apoptotic proteins such as CASP8, CASP9, CASP3 and
PARP1 both in concentration- and time-dependent manner
in tested lung cancer cells, indicating that apoptosis was
trigged after PTL exposure (Figure 1C, D). In addition to
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Figure 2 Parthenolide induces extrinsic apoptosis by up-regulate TNF
manner, and inhibiting TNFRSF10B expression by siRNA decreases pa
were treated with indicated concentrations of PTL for 24 hrs (A) or treated
Western blot analysis (B). A549 (C, D) and H1299 (C, E) cells were seeded i
TNFRSF10B siRNA. A549 cells were treated with 20 μmol/L PTL while H1299
and harvested for Western blot analysis (C) or for detection of apoptotic ce
determinations; bars: S.D. P value < 0.05.arrest in a concentration- dependent manner in A549 cells
and G2/M cell cycle arrest in H1792 cells (Additional file 1:
Figure S1). The difference in cell cycle arrest induced in
these two cell lines may be due to the p53 status [37,38].
Collectively, these results show that PTL inhibits the
growth of human lung cancer cells through induction
of apoptosis and/or cell-cycle arrest.
Parthenolide triggers extrinsic apoptosis by up-regulation
of TNFRSF10B expression
In order to understand the molecular mechanism of
PTL-induced apoptosis in NSCLC cell lines, several
apoptosis-related proteins were examined. Data showed
that TNFRSF10B was up-regulated after exposure to PTL
(Figure 2A, B). After TNFRSF10B expression was knocked
down using siRNA method, the cleavage of CASP8, CASP9,
CASP3 and PARP1 induced by PTL treatment were receded
compared with control siRNA knockdown (Figure 2C).
The analysis of Annexin V staining showed that apop-
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RSF10B in a dose-dependent (A) and a time-dependent (B)
rthenolide–induced apoptosis (C, D and E). The indicated cells
with 20 μmol/L PTL for various lengths of time and harvested for
n 6-well plates and on the second day transfected with control or
cells with 10 μmol/L for another 24 hours after 48 hrs of transfection
lls using Annexin V/PI staining (D, E). Points:mean of three replicate
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regulates TNFRSF10B and contributes to apoptosis in-
duction in lung cancer cells.
CFLAR is down-regulated in parthenolide -induced apoptosis
Since CFLAR is an important modulator of extrinsic
apoptotic pathway, we also detected the levels of CFLAR
and found that both CFLARL (Long form) and CFLARS
(Short form) were down-regulated in a concentration- and
time-dependent manner after PTL treatment (Figure 3A, B).
Compared with control cells, cleavage of pro-caspases
and PARP1 were weaker in A549/CFLARL cells which
over-expressing CFLARL (Figure 3C). Annexin V staining
showed PTL induced less apoptosis in A549/CFLARL cells
than that in control cells (Figure 3D). We got same results
in H157/CFLARL cells (Figure 3C, E). This implicated that
CFLARL could prevent human lung cancer cells from
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Figure 3 CFLAR is down-regulated in parthenolide -induced apoptosi
and overexpression of CFLARL can protect cells from parthenolide-ind
indicated concentrations of PTL for 24 hrs (A) or treated with 20 μmol/L PT
(B). Indicated cells were seeded in 6-well plates and on the second day tre
Western blot analysis (C) or for detection of apoptotic cells using Annexin
S.D. P value < 0.05.summarize that TNFRSF10B and CFLARL are involved in
PTL-induced extrinsic apoptosis.
PMAIP1 and MCL1 contribute to parthenolide -induced
intrinsic apoptosis
We wonder if PTL could also activate intrinsic apoptotic
pathway in lung cancer cells. Since PMAIP1 and MCL1
are both important proteins in intrinsic signaling pathway,
we detected their expression after PTL treatment. Western
blot analysis revealed that MCL1 was decreased in both
concentration- and time-dependent manners after PTL
exposure, while PMAIP1 was up-regulated (Figure 4A, B).
Gene silencing experiment presented that when PMAIP1
was knocked down, the expression of MCL1 was partially
increased and the cleavage of pro-caspases and PARP1 in-
duced by PTL were reduced (Figure 4C). Annexin V stain-
ing analysis showed that apoptosis induced by PTL was
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Figure 4 Parthenolide induces intrinsic apoptosis through up-regulating PMAIP1 expression and down-regulating MCL1 level in a
dose-dependent (A) and a time-dependent (B) manner, and knockdown of TNFRSF10B by siRNA decreases parthenolide–induced
apoptosis (C, D and E). The indicated cells were treated with indicated concentrations of PTL for 24 hrs (A) or treated with 20 μmol/L PTL for
various lengths of time and harvested for Western blot analysis (B). A549 (C, D) and H1299 (C, E) cells were seeded in 6-well plates and on the
second day transfected with control or PMAIP1 siRNA. A549 cells were treated with 20 μmol/L PTL while H1299 cells with 10 μmol/L for 24 hours
after 48hs of transfection and harvested for Western blot analysis (C) or for detection of apoptotic cells using Annexin V/PI staining (D, E). Points:
mean of three replicate determinations; bars: S.D. P value < 0.05.
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induced by PTL is through PMAIP1 and MCL1 axis.
Parthenolide induces apoptosis through activation of ER
stress response
DDIT3, which is a target protein of ATF4, is reported to
regulate the expression of TNFRSF10B and PMAIP1 by
binding to their promoter sites [27]. Therefore, we wonder
if PTL induces TNFRSF10B and PMAIP1 through ATF4-
DDIT3 axis. We examined expression of ATF4 and DDIT3
after PTL treatment. Western blot revealed that PTL could
up-regulate ATF4 and DDIT3 in both concentration- and
time-dependent manner (Figure 5A, B). When ATF4 was
knocked down, DDIT3 was decreased, and activation of
pro-caspases was weakened at the same time compared
with control knockdown cells (Figure 5C). In addition,
apoptosis was suppressed when DDIT3 was knocked down,
while the expression of TNFRSF10B and PMAIP1 were de-
creased simultaneously (Figure 5D). Since ATF4 and DDIT3
are important hallmarks involved in ER stress pathway, we
examined the expression of other molecules in ER stress
signaling such as ERN1, HSPA5 and p-EIF2A as well [39].We found that they were both increased after PTL treat-
ment (Figure 6A, B). All these data indicated that PTL in-
duces apoptosis through activation of ER stress response.
Parthenolide selectively eradicates lung cancer stem-like cells
Weinberg et al. has demonstrated that knocking down
of CDH1/E-cadherin with shRNA could make the cells
have stem-like properties [40]. We had demonstrated that
A549/shCDH1 cells in which CDH1/E-cadherin expression
is inhibited had stronger capacity of proliferation, migration
and invasiveness [32]. Furthermore, we found that the
expression of SOX2 and POU5F1 which were considered
to be the makers of stem cells were up-regulated in A549/
shCDH1 cells (Additional file 1: Figure S2) [41,42]. So
in order to determine why PTL could selectively eradicate
cancer stem-like cells, A549/shCDH1 cell line was used
to mimic cancer stem cells and the A549/shCtrl cell line
served as control. SRB assay showed PTL was more effect-
ive in inhibiting the growth of A549/shCDH1 cells than
that of A549/shCtrl cells (Figure 7A). Western blot data
showed that PTL could induce stronger cleavage of pro-
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Figure 5 Parthenolide induces apoptosis through up-regulating ATF4 and DDIT3 in a dose-dependent (A) and a time-dependent (B)
manner, and knockdown of ATF4 by siRNA decreases parthenolide–induced DDIT3 and apoptosis (C). Knockdown of DDIT3 decreases
parthenolide-induced TNFRSF10B, PMAIP1 expression and apoptosis (D). The indicated cells were treated with indicated concentrations of
PTL for 24 hrs (A) or treated with 20 μmol/L PTL for various lengths of time and harvested for Western blot analysis (B). A549 (C, D) and H1299
(C, D) cells were seeded in 6-well plates and on the second day transfected with control or ATF4 (C) or DDIT3 (D) siRNA. A549 cells were treated
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Figure 6 Parthenolide up-regulates endoplasmic reticulum hallmarks ERN1, HSPA5 and p-EIF2A in a dose-dependent (A) and a
time-dependent (B) manner. The indicated cells were treated with indicated concentrations of PTL for 24 hrs (A) or treated with 20 μmol/L PTL
for various lengths of time and harvested for Western blot analysis (B).
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Figure 7 Parthenolide selectively inhibits cell growth (A) and induces stronger apoptosis (B) in A549/shCDH1 cells and apoptosis, and
ER stress related proteins are up-regulated more clearly by parthenolide in A549/shCDH1 cells than that in control cells (C). Knockdown of
DDIT3 decreases parthenolide–induced PMAIP1 and apoptosis (D). The indicated cell lines were seeded in 96-well plates and treated with the
given concentration of PTL for 24 hrs (A). Live cell number was estimated using SRB assay for calculation of cell survival. Points: mean of four
replicate determinations; bars: S.D. A549/shCtrl and A549 shCDH1 cells were treated with indicated concentrations of PTL for 24 hrs. Both attached
and suspended cells were harvested for Western blot analysis; CF: cleaved form (B,C). A549/shCtrl and A549 shCDH1 cells were seeded in 6-well
plates and on the second day transfected with control or DDIT3 siRNA. Cells were treated with 20 μmol/L PTL for 24 hours after 48 hrs of
transfection and harvested for Western blot analysis (D).
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A549/shCDH1 cells compared with control cells. Further-
more, apoptosis-related proteins were detected in A549/
shCtrl and A549/shCDH1 cells side by side. Both long form
and short form of CFLAR levels were down-regulated even
more clearly in A549/shCDH1 cells than that in control
cells after PTL treatment. We also found that MCL1 was
reduced more dramatically in A549/shCDH1 cells, while
PMAIP1 was up-regulated on contrary after PTL treat-
ment compared with the control cells (Figure 7C). Taken
together, we conclude that both extrinsic apoptosis and
intrinsic apoptosis induced by PTL are enhanced in A549/
shCDH1 cells. The levels of p-EIF2A, ATF4 and DDIT3
were also examined. Data showed that their expression was
further up-regulated in A549/shCDH1 cells after PTL treat-
ment compared with A549/shCtrl cells (Figure 7C). DDIT3
was knocked down in the two cell lines simultaneously, and
PMAIP1 was down-regulated and apoptosis was receded(Figure 7D). Therefore, we propose that the reason why
PTL has a selective effect towards A549/shCDH1 cells
is because PTL somehow triggers much more intensive
ER stress response in cancer stem-like cells and further
enhances the expression of ATF4 and DDIT3, leading to
up-regulation of PMAIP1 and eventually, the induction
of apoptosis.
Discussion
Parthenolide, a sesquiterpene lactone used for therapy of
inflammation, has been reported to have anti-cancer
property. Significantly, recent studies revealed PTL
could selectively eradicate acute myelogenous leukemia
stem cells and breast cancer stem-like cells, but the mo-
lecular mechanism is still unknown. In our study, we found
that PTL can induce apoptosis in NSCLC cells in both
concentration- and time-dependent manner. In addition,
PTL could also induce G0/ G1 cell cycle arrest in A549 cells
Figure 8 Summary of parthenolide-induced signaling pathway
in NSCLC cell lines. Briefly, PTL induces ER stress response and
eventually results in up-regulation of DDIT3 which could increase
the expression of TNFRSF10B and PMAIP1 by binding to their
promoter sites as a transcription factor. As the critical members of
extrinsic and intrinsic apoptotic pathway respectively, TNFRSF10B
and PMAIP1 consequently activate these two pathways to induce
apoptosis in human lung cancer cells.
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to this difference may be is that p53 in A549 cells is
wide type while it is mutant in H1792 cell. However, in
all tested cell lines, PTL induces obvious apoptosis no
matter what the p53 status is.
Subsequently, we detected apoptosis-related proteins
and found TNFRSF10B was up-regulated after PTL
treatment. TNFRSF10B Knockdown resulted in subdued
activation of caspases and apoptosis. Results also showed
that CFLAR was decreased after exposed to PTL. Over-
expressing ectopic CFLARL can weaken the cleavage of
caspases and apoptosis induced by PTL. We conclude that
both TNFRSF10B and CFLAR are responsible for PTL-
induced extrinsic apoptotic pathway.
Proteins involved in intrinsic apoptotic pathway were
also examined in our research. MCL1 was found to be
down-regulated under PTL treatment, while PMAIP1 was
increased on contrary. PMAIP1 Knockdown resulted in
increased level of MCL1 and weakened cleavage of cas-
pases and apoptosis. To summarize, the apoptosis induced
by PTL in lung cancer cells is via both intrinsic and extrin-
sic apoptotic pathways, the intrinsic apoptosis is mediated
through PMAIP1/MCL1 axis.
We and others have reported that DDIT3 could up-
regulate the expression of TNFRSF10B and PMAIP1
[36,43], so we examined DDIT3 expression in PTL-induced
apoptosis. Results showed that DDIT3 was up-regulated by
PTL, and DDIT3 knockdown resulted in reduced expres-
sion of TNFRSF10B and PMAIP1 which leading to weaker
apoptosis compared with control. DDIT3 is an important
molecule in ER stress pathway. We next analyzed whether
PTL could induce ER stress. ERN1, HSPA5, p-EIF2A and
ATF4, which are all key proteins involved in ER stress, were
all up-regulated by PTL in both concentration- and time-
manner. ATF4 Knockdown also led to DDIT3 reduction
and weaker apoptosis. All these results indicated that PTL
can induce apoptosis in lung cancer cells via activation
of ER stress response (Figure 8). PTL is reported to in-
duce ROS which can trigger ER stress response [44]. It
was found that the NAC could protect cell form PTL in-
duced apoptosis, which is the scavenging agent of ROS
[7]. But whether PTL triggers ER stress through ROS in
our system requires future study.
What interested us most is how PTL selectively kills
cancer stem cell. The cells in which CDH1 expression
is inhibited can present properties of cancer stem cells
[32,40]. We found that the expression of stem cell maker
SOX2 and POU5F1/Oct-4 were up-regulated in A549/
shCDH1 cells. So, we used A549/shCDH1 cells to explore
the apoptosis induced by PTL in cancer stem cells. Major
proteins related in PTL-induced signal pathway were
detected. We observed that the level of TNFRSF10B
was increased, and CFLAR was decreased more clearly
in A549/shCDH1 cells compared with A549/Ctrl cellsafter PTL treatment, which could explain the enhanced
cleavage of CASP8. Furthermore, MCL1 level was much
lower, and PMAIP1 level was much higher in A549/
shCDH1 cells than that in control cells after PTL expos-
ure. Although the basal levels of p-EIF2A in the two cell
lines were almost equal, it was up-regulated more clearly
in A549/shCDH1 cells than that in control cells after PTL
treatment. In addition, ATF4 and DDIT3 were both up-
regulated in A549/shCDH1 cells more dramatically than
that in control cells after exposure with PTL. Afterwards,
we knocked down DDIT3 in the two cell lines side by side
and found that PMAIP1 was down-regulated, and apop-
tosis was receded. We propose that the reason why PTL
has a selective effect towards cancer stem-like cells is that
PTL somehow induced stronger ER stress response and
further enhances the expression of ATF4 and DDIT3,
which leads to up-regulation of PMAIP1 and eventually,
the apoptosis induction in cancer stem-like cells.
In summary, our work demonstrates that parthenolide
induces both extrinsic and intrinsic apoptosis via ER stress
signaling pathway in human NSCLC cells (Figure 8).
Moreover, parthenolide induces stronger ER stress and
apoptosis in cancer stem-like cells which may account
for its selective effect in apoptosis induction. Collect-
ively, this study provides important mechanistic insight
into potential cancer treatment with parthenolide as
well as our understanding for cancer stem cells.
Additional file
Additional file 1: Figure S1. Parthenolide induces cell cycle arrest in
NSCLC cell lines. A549 (A) and H1792 (B) cells were treated with different
concentrations of PTL for 24 hours. After treatment, the cells were
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http://www.jeccr.com/content/33/1/3harvested for cell cycle assays. Figure S2. Cancer stem cell makers are
up-regulated in A549/shCDH1 cells. The expression level of SOX2 and
POU5F1 were detected in A549/shCtrl and A549/shCDH1 cells by Western
Blot assay.
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